AI Model for Predicting Binding Affinity of Antidiabetic Compounds Targeting PPAR
This study aims to develop a deep learning model for predicting the binding affinity of ligands targeting the Peroxisome Proliferator-Activated Receptor (PPAR) family, using 2D molecular descriptors. A dataset of 3,764 small molecules with known binding affinities, sourced from the ChEMBL database, was preprocessed by eliminating duplicates and incomplete data. Molecular docking simulations using AutoDock Vina were performed to predict binding affinities for the PPAR receptor family. 2D molecular descriptors were computed from the SMILES notation of each ligand, capturing essential structural and physicochemical features. These descriptors, along with the predicted binding affinities, were used to train a deep learning model to predict binding affinity as a regression task. The model was evaluated using metrics such as Mean Squared Error (MSE), Mean Absolute Error (MAE), and R-squared. Results indicated strong performance with an R squared value of 0.861 for the training set and 0.655 for the test set, suggesting good model generalization. The model shows promise for predicting ligand-receptor interactions and can be applied in drug discovery efforts targeting PPAR-related diseases.
Code (0)
등록된 구현이 없습니다.
Tasks
Drug DiscoveryMolecular DockingMethods 이 논문이 사용한 방법론
Similar Papers 제목 키워드 기반
Artificial Intelligence Powered Identification of Potential Antidiabetic Compounds in Ficus religiosa
Diabetes mellitus is a chronic metabolic disorder that necessitates novel therapeutic innovations due to its gradual progression and the onset of various metabolic complications. Research indicates that Ficus religiosa i…
DeepDTA: Deep Drug-Target Binding Affinity Prediction
The identification of novel drug-target (DT) interactions is a substantial part of the drug discovery process. Most of the computational methods that have been proposed to predict DT interactions have focused on binary c…
Binary ClassificationDrug DiscoveryPredictionHybrid quantum-classical convolutional neural networks to improve molecular protein binding affinity predictions
One of the main challenges in drug discovery is to find molecules that bind specifically and strongly to their target protein while having minimal binding to other proteins. By predicting binding affinity, it is possible…
Drug DiscoveryQuantum Machine LearningComputational Analysis using Multi-ligand Simultaneous Docking of Withaferin A and Garcinol Reveals Enhanced BCL-2 and AKT-1 Inhibition
Developing an effective medicine to combat cancer and elusive stem cells is crucial in the current scenario. Withaferin A and Garcinol, important phytoconstituents of Withania somnifera (Ashwagandha) and Garcinia indica …
Molecular DockingGenShin:geometry-enhanced structural graph embodies binding pose can better predicting compound-protein interaction affinity
AI-powered drug discovery typically relies on the successful prediction of compound-protein interactions, which are pivotal for the evaluation of designed compound molecules in structure-based drug design and represent a…
Drug DesignDrug Discovery